Clearline Capital’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
Clearline Capital's ABVX Position: Q3 2026 in Review
Clearline Capital opened a new position in Abivax (ABVX) in Q3 2026: 31,152 shares worth $3.08M. The stake represents 0.14% of the portfolio and ranks #89 among its holdings.
319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Clearline Capital held 31,152 shares of Abivax worth $3.08M as of Q3 2026.
- Abivax was a new Clearline Capital position in Q3 2026.
- Abivax made up 0.14% of Clearline Capital's portfolio in Q3 2026, its #89 holding.
- 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Clearline Capital's 13F filing for Q3 2026, filed 16 Nov 2026.